Magazine article Drug Topics

Home Health, Mail Order Lead Pharmacy Gainers

Magazine article Drug Topics

Home Health, Mail Order Lead Pharmacy Gainers

Article excerpt

More unit sales, more use of higher-priced products, price hikes, and more data collection pushed total U.S. Rx pharmaceutical sales to $56 billion in 1992, according to IMS America's latest class of trade analysis.

Measured in manufacturers' dollars, pharmaceutical sales posted an adjusted growth rate of 13.3% last year over the previous year, reported IMS America, a Dun & Bradstreet company that tracks data covering about 98% of the U.S. market. The market's growth rate was down from the 17.7% gain in 1991. Frank Deardorff, IMS America's group sales director, believes that restraint on price hikes accounted for the dip in the rate of growth.

Pharmacy's big three--chains, hospitals, and independents--maintained their hold on the pharmaceutical market, accounting for $38.9 billion in sales, or 69.4% of the market tracked by IMS America. Chain sales were $13.7 billion, up 10.2%, while hospital sales grew by 6.7% to $12.5 billion, and independents posted sales of $12.6 billion, a 6.8% gain.

On the other hand, the trio that traditionally holds the Rx high ground continued to lose market share. The biggest gainers last year were the visiting nurse/home health-care segment, which grew by an adjusted rate of 52%. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.